Status:
COMPLETED
Follow-Up Study for Exubera
Lead Sponsor:
Pfizer
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Brief Summary
In studies of Exubera in persons with diabetes, lung cancer occurred in a few more people who were taking Exubera than in people who were taking other diabetes medicines. All subjects diagnosed with l...
Detailed Description
Both retrospective and prospective components All subjects who participated in one of the 17 included Exubera clinical trials will be invited to participate in the current study.
Eligibility Criteria
Inclusion
- Previously participated in an eligible Exubera clinical trial
- Willing to provide study doctor with at least one alternate contact person
Exclusion
- Participated in an investigational study of an unapproved drug since completing the Exubera trial
- Ever used an other (non-Exubera) inhaled insulin
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
7439 Patients enrolled
Trial Details
Trial ID
NCT00734591
Start Date
August 1 2008
End Date
January 1 2012
Last Update
October 23 2012
Active Locations (321)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Bay Minette, Alabama, United States, 36507
2
Pfizer Investigational Site
Graysville, Alabama, United States, 35073
3
Pfizer Investigational Site
Pell City, Alabama, United States, 35125
4
Pfizer Investigational Site
Pell City, Alabama, United States, 35128